XML 21 R71.htm IDEA: XBRL DOCUMENT v2.4.0.6
Contingencies (Details) (USD $)
In Millions, unless otherwise specified
0 Months Ended 9 Months Ended 9 Months Ended 9 Months Ended 9 Months Ended 12 Months Ended 0 Months Ended 9 Months Ended
Apr. 16, 2012
Sep. 30, 2012
Sep. 30, 2012
Lorazepam And Clorazepate
Jun. 19, 2012
Lorazepam And Clorazepate
May 30, 2012
Lorazepam And Clorazepate
Feb. 06, 2008
Lorazepam And Clorazepate
plantiffs
Jun. 01, 2005
Lorazepam And Clorazepate
drugs
May 16, 2005
Lorazepam And Clorazepate
insurers
Dec. 31, 2001
Lorazepam And Clorazepate
insurers
Sep. 30, 2012
Pricing And Medicaid Litigation
counties
Dec. 31, 2011
Pricing And Medicaid Litigation
Apr. 27, 2006
Modafinil Antitrust Litigation and FTC Inquiry
other_drug_manufacturers
Apr. 25, 2008
Digitek Recall
Sep. 30, 2012
EU Commission Proceedings
Jul. 08, 2009
EU Commission Proceedings
other_companies
Sep. 30, 2012
Product Liability
Dec. 31, 2011
Product Liability
Dec. 31, 2010
Product Liability
Apr. 16, 2012
Intellectual Property
D
May 24, 2011
Intellectual Property
Sep. 30, 2012
Intellectual Property
Loss Contingencies [Line Items]                                          
Accrued amount for settlement             $ 12.0     $ 55.0 $ 115.0             $ 41.0      
Number of drugs found to be in violation of antitrust laws             2                            
Number of health insurers who brought on the antitrust claims                 4                        
Number of insurers dismissed due to filed motion by the Company following verdict               2                          
Judgment amount           69.0                              
Number of plaintiffs in which judgement issued reflects trebling of the compensatory damages           3                              
Compensation damages in original verdict           11.0                              
Compensatory damages in original verdict plus punitive damages           58.0                              
Value of damages sought     8.0                                    
Voluntary remittitur from plaintiffs       8.1                                  
Surety bond underwritten by third-party insurance company     74.5   66.6                                
Approximate number of counties in New York State involved in the civil lawsuit                   40                      
Settlement payments                   82.6           21.9 15.0        
Accrual of loss contingency                   20.0                      
Estimate of anticipated income tax benefits due to acquiree                   67.9                      
Number of other drug manufactures named as defendants in the civil lawsuit                       4                  
Number of cases pending                         1,000                
Number of other companies involved in anti-trust proceedings                             4            
Number of companies involved in inquiry                           100              
Plantiff bond payment                                       10.0  
Injunction period post mandate, days                                     45    
Amount of times damages may be increased in cases of willful infringement                                         3
Collective bargaining agreement term 5 years                                        
Multiemployer plan withdrawal liability   $ 15.4